Submitted by Anonymous (not verified) on 26 January 2026 - 15:02
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 25, Status: Authorised